Sunnyvale, CA, United States of America

Joseph I DeGraw


Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 205(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (1980 - 1996)
  • Missoula, MT (US) (2000 - 2001)
  • Mountain Brook, AL (US) (2022)

Company Filing History:


Years Active: 1980-2022

Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Joseph I DeGraw

Introduction

Joseph I DeGraw, based in Sunnyvale, CA, has made significant contributions to the field of pharmaceuticals, evidenced by his impressive portfolio of 22 patents. His innovative work has focused on advanced methods for drug development, particularly in creating derivatives of existing compounds that may revolutionize treatment protocols.

Latest Patents

Among his latest patents is a method for the facile conversion of morphine to normorphine. This invention presents methods for making an N-demethylated derivative of morphine, which can be substituted at the N—H position with various ligands. These new morphine derivatives could potentially possess increased analgesic efficacy, reduced addictive properties, and improved anti-opiate characteristics capable of aiding recovery from opiate drug overdose situations.

Another notable patent involves the combination therapy of 10-propargyl-10-deazaaminopterin and taxols for treating tumors. Preliminary clinical studies have demonstrated the efficacy of 10-propargyl-10-deazaaminopterin, establishing a preferred dosage schedule. Furthermore, the combination of this compound with taxols shows a synergistic effect in tumor treatment, highlighting the potential for improved therapeutic outcomes.

Career Highlights

Joseph I DeGraw has maintained a dynamic career with affiliations at Sri International, where he honed his skills in innovative research and pharmaceutical development. His vast experience in patent filings underscores his role as a key player in his field, contributing to both scientific advancements and patent law.

Collaborations

Throughout his career, DeGraw has collaborated with esteemed colleagues, including Francis M. Sirotnak and William T. Colwell. These collaborations have led to fruitful research endeavors, further advancing the understanding and treatment of various medical conditions.

Conclusion

Joseph I DeGraw's relentless pursuit of innovation in pharmaceuticals exemplifies the vital role of inventors in shaping the future of healthcare. His contributions through patents not only enhance the efficacy of treatments but also pave the way for safer alternatives to existing medications. The ongoing impact of his work will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…